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Objective: The study aimed to investigate the impact of new onset diabetic 
ketoacidosis (DKA) upon brain morphology and function.  
Research Design and Methods: Patients aged 6-18 years with and without DKA at 
diagnosis were studied at four time points: <48 hours, five and 28 days, and six 
months post diagnosis. Patients underwent magnetic resonance imaging and 
spectroscopy with cognitive assessment at each time point. Relationships between 
clinical characteristics at presentation and magnetic resonance imaging and 
neurologic outcomes were examined using multiple linear regression analyses, 
repeated measures and ANCOVA analyses. 
Results:  Thirty-six DKA and 59 non-DKA patients were recruited between 2004-9. 
With DKA, total white matter volume was increased at baseline and decreased over 
six months with altered diffusion measures in the frontal, temporal and parietal 
cortices on day one relative to non-DKA patients. For grey matter in DKA patients, 
total volume was lower at baseline and increased over six months. Lower levels of N-
acetyl aspartate were noted at baseline in the frontal grey matter and basal ganglia. 
Mental state scores were lower at baseline and at five days. Importantly, changes in 
total and regional brain volumes over the first five days were associated with poorer 
delayed memory recall, and focused, sustained, and divided attention at six months. 
Multiple regression analysis demonstrated that pH and age at the time of 
presentation were strong predictors of the aforementioned outcomes.  
Conclusions: DKA at type 1 diabetes diagnosis results in morphologic and functional 
brain changes that are associated with adverse neurocognitive outcomes in the 
medium term. 
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The incidence of childhood onset type 1 diabetes varies from 0.1 to 57.6 per 100,000 
and is increasing worldwide(1). Long-term cognitive consequences of type 1 diabetes 
and associated fluctuations in glycemia during childhood and adolescence are well 
documented (2). Developing strategies to prevent or ameliorate these adverse 
outcomes requires an understanding of the nature and timing of the neurological 
insults associated with diabetic dysglycemia.   
 
The most severe acute diabetes-related central nervous system complication in type 
1 diabetes is cerebral oedema associated with diabetic ketoacidosis (DKA) (2) with 
10-25% of affected children experiencing chronic CNS morbidity (3). Whilst the 
frequency of DKA at diagnosis is relatively high (15-70% depending upon age and 
geographic region), fulminate clinical cerebral oedema in this context is relatively rare 
with an incidence rate of only 0.5-0.9% (4) and hence documented brain injury is also 
rare. The more frequent, milder alterations in brain function and chemistry in newly 
diagnosed DKA have been assumed to be transitory with normalisation after 
metabolic stabilisation (5-8), but this assumption has not been formally tested. We 
hypothesized that just as there exists a continuum of clinical and sub-clinical cerebral 
oedema (9), there may also be a continuum of brain injury in DKA and that brain 
injury outside the context of cerebral oedema may be more common than previously 
recognised.  The purpose of this study in children with new onset DKA was two-fold – 
firstly, to document acute alterations in magnetic resonance imaging (MRI) measures 
of cerebral structure and cognitive function and correlate these with clinical 
parameters; and secondly, to study the evolution of these alterations in brain 
structure and cognitive functioning over the first six months.   
 
RESEARCH DESIGN AND METHODS  
We conducted a prospective, longitudinal cohort study at the Royal Children’s 
Hospital (RCH), Melbourne, Australia between June 2004 and October 2009 of 
English-speaking children aged between 6-18 years who presented with a new 
diagnosis of type 1 diabetes. The diabetes clinic at RCH provides services to 
approximately 75% of children in Melbourne (population of 4.17 million) with diabetes 
living within a large, socio-demographically and ethnically diverse region. The type 1  
diabetes clinic population consists of 1650 children and adolescents aged up to 19 
years with 2-3 children being diagnosed at our centre each week. Patients were 
recruited sequentially as they presented to RCH at diagnosis. The patients 
underwent MRI, magnetic resonance spectroscopy (MRS) and cognitive evaluation 
at four time points: “Baseline” was within 48 hours of presentation, “Day 5” was 
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between 5 and 7 days, “Day 28” was between 26-30 days and “6 months” was 25-27 
weeks after presentation. Exclusion criteria were pre-existing neurological 
abnormality, neurologic impairment, evidence of any congenital abnormality or 
established brain injury on MRI, clinical signs consistent with a diagnosis of cerebral 
oedema (headache with obtundation or deterioration in Glasgow Coma scale score, 
bradycardia with hypertension), the presence of metal-wired orthodontic braces and 
inability to undergo MRI without general anaesthesia.  Of 205 eligible children, 95 
children were enrolled in the study - 36 with DKA, defined as serum pH <7.30, and 
59 without DKA. Clinical status of participants (DKA vs non-DKA) was classified 
unambiguously according to parameters that were measured biochemically in a 
NATA (National Association of Testing Authorities- Australia) accredited laboratory. 
The device that was used to measure pH was a Siemans Rapidlab 1260 machine 
with a measurement of uncertainty is +/- 0.02. All patients were treated as per 
standard hospital protocol 
(http://www.rch.org.au/clinicalguide/guideline_index/Diabetes_Mellitus). The study 
was approved by the Royal Children’s Hospital Human Research Ethics Committee. 
 
Measures 
Clinical and Demographic Information 
Clinical information collected from all children at diagnosis included age, sex, weight, 
height, blood pressure, pulse rate and serum biochemical measures (pH, CO2, 
HCO3, base excess, glucose, osmolality, sodium, urea). Percent dehydration was 
calculated according to: [(discharge weight minus admission weight)/discharge 
weight] x 100. Socioeconomic status (SES) was rated according to Victorian 
geographical postal area using the Australian Bureau of Statistics Socio-Economic 
Indices for Areas (10). Parents also provided information on their child’s 
developmental and academic history. 
 
The following data were collected at each assessment: height, weight, number of 
severe hypoglycemia reactions, number of episodes of recurrent DKA, co-
morbidities, insulin dose and regimen, and glycated hemoglobin. Severe 
hypoglycemia was defined as hypoglycemia associated with loss of consciousness 
and/or seizure or altered conscious state that required therapy from another person. 
DKA was defined in the same way (serum pH < 7.30) as at presentation.  Insulin 
dose adjusted A1C levels were calculated as an index of degree of residual 
endogenous insulin secretion (11). 
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Magnetic resonance imaging  
Brain imaging was performed using a Siemens Trio 3T scanner. Images were 
acquired using the standard quadrature head coil at four time points. Transverse, T2-
weighted images were acquired using a turbo spin echo sequence (TR/TE 6400/93 
ms, echo train length 17, slice thickness 3.5 mm, in-plane resolution 0.51 x 0.51 
mm). T1-weighted images were acquired using an MPRAGE sequence with 
contiguous slices (TR/TE/TI 1900/2.19/900 ms, flip angle 9°, contiguous slices 1 mm3 
isotropic spatial resolution).  Diffusion data were acquired with a spin-echo EPI 
sequence using one of two image parameter sets.  The first was TR/TE 6000/97 ms, 
slice thickness 3 mm, in-plane resolution 1.5 x 1.5 mm, b amplitude 1000 x 10-3 
s/mm2 with 20 directions.  The second was TR/TE 4000/89, slice thickness 4 mm, in-
plane resolution 1.7 x 1.7 mm, b amplitude 1000 x10-3 s/mm2 with 24 directions plus 
five b=0 acquisitions.   
 
Cortical and volumetric segmentation were performed with Freesurfer 4.4 
(http://surfer.nmr.mgh.harvard.edu/) using the T1 weighted images. Volumes were 
determined for both cortical and subcortical regions (12).  Parcellated brain volumes 
were combined into larger regions matching the regions for diffusion analysis.  These 
included frontal, temporal and parietal regional volumes (Appendix 1), and expressed 
as a proportion of the total brain volume (TBV) to normalise for age-related variations 
in brain size. 
 
Raw data from the diffusion acquisitions were phased using a Bayesian procedure 
(13) to provide images with Gaussian noise centred about zero.  The images were 
aligned to the corresponding T2-weighted image data set.    Diffusion encodings 
corrupted by subject motion were automatically identified and removed.  Parametric 
maps were generated for mean diffusivity (MD) and fractional anisotropy (FA).  
Diffusion Tensor Imaging (DTI) parameter sampling was performed using Analyze, 
version 9·0 (Mayo Clinic, Rochester, MN). A data analyst blinded to subject status 
placed regions of interest in the grey and white matter of the frontal, temporal, and 
parietal lobes (Figure 1, Appendix 1).  
 
Magnetic resonance spectroscopy  
Single-voxel, water-saturated spectra were acquired using a standard PRESS 
sequence. Regions of interest included the left frontal white matter, frontal grey 
matter, and left basal ganglia, each previously identified as vulnerable (7, 14). The 
ROIs were positioned using T1-weighted scout images. Basal ganglia ROIs were 
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positioned over the lentiform nuclei; frontal lobe white matter ROIs were positioned 
above the anterior tip of the left lateral ventricle, and frontal lobe grey matter ROIs 
were placed in the same plane as the white matter voxel, anterior to and at the level 
of the corpus callosum within cingulate grey matter.  Acquisitions comprised 80 
transients recorded with a TE/TR = 30/3000 ms. The voxel placed in the basal 
ganglia was 20 x 20 x 10 mm and the frontal lobe voxels were 25 x 20 x 15 mm. All 
measurements were made using the same 3T Siemens instrument ustilising a 
quadrature head coil. Metabolite concentrations are presented relative to creatine 
concentration. The values for N-acetylaspartate (NAA) reported here include its NAA-
glutamate component (reported as NAA).  NAA is considered a marker of neuronal 
density.  Myoinositol concentration is an endogenous osmolyte that is considered a 
marker of gliosis. Tissue metabolite content was determined using LCModel (15) with 
a basis set of 21 metabolites prepared using reference solutions.  
 
Cognition  
Mental state: At Day 1 tests were limited to those that could be administered bedside 
to unwell children.  Hence the only tests administered were the Mental State School-
Years Screening Test for the Evaluation of Mental Status (SYSTEMS) (16) and a 
paired associate verbal learning task. The SYSTEMS was developed as a child-
appropriate alternative to the adult Mini-Mental State Examination (17) on which it is 
based. It was developed in a pediatric hospital to measure subtle changes in mental 
state and cognition in the context of both acute and chronic illness or brain injury. 
The SYSTEMS was administered at days one and five after admission. Responses 
were classified using age-specific cut-off scores (16). 
 
Intelligence: The Wechsler Intelligence Scale for Children - Fourth Edition (WISC-IV) 
(18) was administered six months after admission. An age-standardised summary 
Full Scale IQ score (M=100, SD=15) was calculated.  
 
Memory: Verbal memory was assessed at each time point using a paired associate 
learning task requiring children to learn novel word pairs and recall them after a delay 
(19). Alternative forms of the test were used to minimise practice effects. The 
numbers of words remembered after a delay was reported.  
 
Attention: Four tasks (Sky Search-focused attention; Sky Search Dual Task – dual 
modality divided attention; Score Dual Task – single modality divided attention; and 
Walk/Don’t Walk – sustained attention/impulsivity) from The Test of Everyday 
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Attention for Children (TEA-Ch) (20) were administered at five days, 28 days and six 
months after acute presentation. Age and gender standardised scores were reported.  
 
Statistical Analysis 
All data (Appendix 2) were analysed using SPSS version 20 (SPSS Inc.). Groups 
(DKA/non-DKA) were compared using ANOVA and ANCOVA (continuous variables) 
and χ2 (categorical variables) analyses. Age at presentation and gender were added 
as covariates in all analyses involving non-age and non-gender adjusted variables. 
Change in neurologic outcome over time was investigated using repeated measures 
ANCOVA. Relationships between clinical characteristics at presentation and 
neurologic outcomes were examined using multiple linear regression analyses with 
age at presentation and gender entered as additional predictors. Regression 
diagnostics were performed and no issues of multicollinearity among independent 
variables were identified.  Data for this model are also presented in terms of 
percentage of variance accounted for by the individual predictor (sr2). Proportionate 
changes in brain measures at presentation were calculated according to (measured 
value at day five minus measured value at day one/value at day five). The 
proportionate volume changes were correlated with cognitive outcome variables at 
six months. All analyses were two-sided and a Bonferroni correction was applied 
resulting in an alpha level of 0.01.  
 
RESULTS 
The characteristics of the participants are described in Table 1. Participant numbers 
were 36/59, 29/46, 27/46 and 25/44 (DKA/non-DKA) at the four time points 
respectively. There were no differences between the DKA and non-DKA groups in 
age, duration of symptoms, SES and educational history. Following diagnosis, the 
groups did not differ in frequency of severe hypoglycemia, recurrent DKA, thyroid or 
celiac disease, or by insulin regimens or glycated hemoglobin (raw or insulin 
adjusted).  
 
Magnetic resonance imaging and spectroscopy measures 
Total Cerebral Volumes: Total supratentorial brain volumes did not differ with DKA at 
any time point (Figure 1) and did not change over time in either group.   
White Matter:  Relative total white matter volume was increased in the DKA group at 
baseline (F=7·43, p=0·008, Figure 1) and decreased over six months (F=25·72, 
p<0·001). For regional analysis, relative frontal white matter volume was increased 
with DKA at baseline (F=10·84, p=0·002, Figure 2) and decreased over six months 
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(F=16·56, p=0·001). A decrease in relative parietal white matter volume also 
occurred over six months in the DKA group only (F=9·19, p=0·008). For diffusion 
measures, with DKA white matter diffusivity at baseline was higher in the frontal lobe 
(F=18·78, p<0·001, Figure 2), temporal lobe (F=18·12, p<0·001) and parietal lobe 
(F=13·42, p<0·001). Reductions in white matter diffusivity occurred over six months 
with DKA in the frontal (F=11·08, p=0·006, Figure 2), temporal (F=42·20, p<0·001) 
and parietal (F=16·63, p=0·002) lobes. Fractional anisotropy changed in the opposite 
direction, but parallel to the diffusivity over all analyses. Spectroscopy revealed 
frontal white matter NAA levels were lower with DKA at Time 4 (F=8·51, p=0·005, 
Figure 2). There was a trend toward an increase in frontal white matter NAA levels 
over six months in the non-DKA group (F=6·186, p=0·02), but no change in the DKA 
group. 
Grey Matter:Relative total cortical grey matter volume was decreased with DKA on 
day one (F=7·64, p=0·008, Figure 1) and increased over six months (F=10·18, 
p=0·005). Regionally, the relative temporal cortical grey matter volume was 
decreased with DKA on day one (F=8·66, p=0·005), with a trend to increase over six 
months.  For diffusion, parietal lobe grey matter diffusivity was higher with DKA on 
day one (F=10·2, p=0·002). Grey matter diffusivity in the frontal lobes decreased 
over six months with DKA (F=50·232, p<0·001, Figure 2) and was lower at six 
months (p=0·01). For spectroscopy, frontal grey matter NAA levels were lower on 
day one with DKA (F=8·73, p=0·005, Figure 2), while myoinositol levels decreased 
over six months (F=14·827, p=0·002).  
Hippocampus and basal ganglia: Relative hippocampal and basal ganglia volumes 
did not differ with DKA at any time point. There was no change in either volume over 
six months. In the left basal ganglia, NAA levels with DKA trended lower on day one 
(F=5·24, p=0·03) and day five (F=7·29 and p=0·01).  
 
Cognition 
The mental state score was lower with DKA on day one (Figure 3, F=10·14, 
p=0·002), with both groups showing a similar improvement by day five (DKA 
F=28·77, p<0·001; non-DKA F=21·42, p<0·001). There were no group differences on 
Full scale IQ at six months. Memory scores were lower with DKA on day one 
(F=14·58, p<0·001) and improved by six months (F=8·22, p=0·009, Figure 3). No 
differences in memory, divided or sustained attention were noted with DKA at six 
months. Focused attention improved between day five and six months in the non-
DKA group (F=13·73, p=0·001, Figure 3), but not in the DKA group.  
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Clinical parameters on admission and MRI and cognitive outcomes  
Lowest pH and age at presentation were the strongest predictors of MRI and MRS 
measures and cognitive outcomes. The day one lowest pH was positively related 
with change in total brain volume by day five (sr2=7·1%, p=0·008); negatively 
associated with day 1 white matter diffusivity in the frontal (sr2=41·3%, p<0·001), 
temporal (sr2=33·03%, p<0·001) and parietal regions (sr2=24·07%, p<0·001); but 
positively associated with six month frontal grey matter diffusivity (sr2=119·66%, 
p=0·015). Day one lowest pH was also positively associated with day one frontal 
grey matter NAA levels (sr2=16·86%, p=0·001) and day one memory (17·47%, 
p<0·001).  
 
Age at presentation was positively related to diffusion measures on day one in frontal 
and parietal grey matter diffusivity (sr2=22·84%, p<0·001 and sr2=21·87%, p<0·001) 
and negatively associated with day one frontal and temporal white matter diffusivity 
(sr2=10·36%, p<0·001; sr2=11·46%, p=0·001 respectively). Age at presentation was 
positively associated with six month frontal (sr2=17·91%, p=0·001) and parietal grey 
matter diffusivity (sr2=19·70%, p=0·001).  
 
In the DKA group univariate and multivariate analyses of MR outcomes and the 
timing of the first scan (expressed as hours between the time of commencement of 
intravenous resuscitation and time of scan) showed there were no significant 
associations between any of the volumetric and spectroscopic outcomes and time of 
first  scan. There was a significant association between the time of the scan and 
parietal grey matter MD seen on univariate analysis that was not significant on 
multivariate analysis. There were no other significant associations between MD and 
timing of scan. 
 
 
MRI measures in the first week and 6 month cognitive outcomes 
The reduction between days one and five in total white matter volume (an indirect 
measure of swelling) was negatively associated with performance on dual modality 
divided attention (r=-0·46, p=0·002) and sustained attention (r=-0·40, p=0·007) at six 
months. Frontal white matter volume reduction was negatively associated with dual 
modality divided attention (r=-0·43, p=0·004); temporal white matter volume 
reduction was negatively associated with long-term memory (r=-0·49, p=0·0009); and 
parietal white matter volume reduction was negatively associated with sustained 
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attention (r=-0·47, p=0·002). Parietal grey matter volume increase was negatively 
associated with sustained attention (r=-0·45, p=0·002).  
 
CONCLUSIONS  
This study highlights the common nature of focal cerebral oedema, and associated 
impairment in mental state, at the time of presentation with new-onset type 1 
diabetes in middle childhood. We demonstrate that these alterations occur most 
markedly throughout the cerebral white matter, particularly in the frontal lobes and 
are most prominent in the youngest children with the most dramatic acidemia. 
Changes in cerebral MRI measures over the first week after diagnosis were 
associated with persisting alterations in attention and memory functioning six months 
later. Children with DKA did not otherwise differ in age, sex, SES, pre-morbid 
learning difficulties or in post-diagnosis clinical trajectory. Earlier diagnosis of type 1 
diabetes in childhood may avoid the complication of DKA, with the neurological 
consequences documented in this study, and is worthy of a major public health 
initiative.  
 
This study utilizes several MRI techniques to define cerebral structure and 
biochemistry. All regional brain volume data were normalized to account for 
differences in absolute volume related to varying subject age. Thus, the measures 
from day one showed a relative increase in white matter volume and decrease in 
grey matter volume. With DKA, white matter volume expansion was greatest within 
the frontal white matter but a more widespread reduction in parietal and frontal white 
matter volume was seen over the first six months following diagnosis. Unlike 
volumes, diffusion values were not normalized, as they are comparatively stable 
throughout childhood (21). Diffusion values in the DKA group were high on day one 
throughout all white matter regions evaluated, but returned to non-DKA levels by day 
five. We postulate that increases in both volume and diffusivity within the white 
matter were due to increased tissue water, and this is supported by strong 
correlations between the reduction in volume and decrease in diffusivity. It is notable 
that the diffusivity appeared to be more sensitive than volume, as an increase in 
white matter volume was detected only for frontal white matter. This finding also 
suggests a greater vulnerability for the frontal white matter in DKA, which may 
represent a maturational vulnerability as the frontal white matter remains immature at 
this period of cerebral development. 
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We propose two explanations, which are not necessarily mutually exclusive, for the 
increased volume and altered diffusion that is prominent acutely in the white matter: 
1) the osmotic effects caused by relatively rapid restoration of blood glucose (and 
osmolarity) in the face of slower loss of idiogenic osmoles in axons and myelin 
leading to cell swelling; and/or 2) the breakdown of the blood brain barrier leading to 
extravasation of fluid into the white matter interstitium with extracellular (vasogenic) 
oedema.  These disturbances in brain water balance can be viewed as being 
analogous to those associated with extrapontine myelinolysis, which is typically found 
in conjunction with fluid/electrolyte disturbances and has been associated with 
diabetes (22, 23). Our findings are consistent with other studies suggesting brain 
water shifts associated with DKA (9) including increased diffusion in the frontal white 
matter in the first hours of management (14). Further evidence of white matter 
pathology was demonstrated in two atypical comatose, pediatric DKA cases without 
cerebral edema in which subcortical white matter micro-hemorrhage and 
inflammation were noted (24).  
 
Additional insight is provided from the MRS. Acutely, frontal grey matter 
demonstrated a reduction in NAA which recovered.  This may reflect neuronal 
dysfunction, emphasizing neuronal impact from DKA. Over the first six months 
following diagnosis, the greatest alterations on spectroscopy were reductions in 
frontal white matter NAA.  Whereas a typical maturational increase in NAA occurred 
in children without ketoacidosis (25), this was not seen in the children who presented 
with DKA.  Reductions in frontal white matter and basal ganglia NAA have previously 
been associated with impaired cognition (26) and DKA (27-29). In addition from the 
MRS, lactate was present in approximately 10% of both DKA and non-DKA subjects 
in any voxel.  This low incidence of an elevation in lactate may relate to the delay in 
imaging after the initiation of therapy. 
 
Two recent cross-sectional retrospective studies have highlighted a negative impact 
of ketoacidosis on cognitive performance in school-aged children with existing 
diabetes (30-31). For the current study, the strength of examining patients with new 
onset diabetes has allowed the window of dysglycemia to be simplified to a single 
period of hyperglycemia with or without one episode of ketoacidosis. Interestingly, 
our findings replicate a similar uni-dimensional model of cognitive performance in rats 
after one episode of DKA (32).  
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In relation to clinical risk factors, the degree of acidosis and younger age appeared to 
be the greatest risk factors for alterations in cerebral structure. Younger age has 
been previously described as being associated with greater degree of cognitive 
impairment in type 1 diabetes (2). These previous studies have included children 
exposed to various aspects of diabetes dysglycemia, including hypoglycemia. 
Specific studies of DKA in children have been thus far limited to cerebral oedema. In 
these, the risk of cerebral oedema was associated only with elevation in serum urea 
and low partial pressures of arterial carbon dioxide (33). In children and adults with 
DKA without cerebral oedema, the degree of acidosis was the determinant of 
impaired conscious state (6, 34).  
 
Finally, cerebral volume changes in the frontal, temporal and parietal regions in the 
first week after diagnosis were associated with lower attention and memory scores 
six months later. This suggests new onset DKA in childhood may have irreversible 
impacts on the brain, with functional information processing difficulties persisting after 
resolution of tissue water increases in cerebral white matter. These findings have not 
been reported to date, but are consistent with the growing concern over academic 
performance in school-aged children with diabetes (2). 
  
The lack of pre-morbid data on MR brain volumes, diffusivity, spectroscopy and 
cognition is an unavoidable limitation of this study. There are currently no screening 
programs that practically identify those children and adolescents destined to develop 
type 1 diabetes in low risk populations. If there were such screening programs, it 
would be unethical to allow such children to develop DKA. However, given the fact 
that the DKA and non-DKA groups did not differ in any demographic variables or 
previous history of learning difficulty and that the variations in brain morphology 
aligned temporally and statistically to the episode of acidosis, we surmise that the 
likelihood of significant pre-morbid differences in brain structure and function 
between the two groups is low. Another possible limitation relates to the period of 
DKA prior to admission. Given the severity of the clinical phenotype of DKA any 
variation in duration would be a matter of hours rather than days and is to some 
extent reflected by the degree of acidosis, however exact duration remains unknown. 
An additional limitation relates to the short follow up period of 6 months. However the 
longer the follow-up period, the greater the likelihood of post-diagnosis glycemic 
events (recurrent episodes of DKA, episodes of severe hypoglycemia, prolonged 
periods of hyperglycemia etc) contributing to brain injury. Thus, balancing the need 
for allowing for time for recovery yet avoiding additional clinical confounders, 6 
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months was chosen as the follow-up period to provide the best picture of the 
neurological sequelae of the initial DKA insult.   A final limitation relates to the fact 
that only three quarters of the subjects completed all data collection. This may 
introduce some bias in the later evaluations. 
 
Conclusions and clinical implications 
This study demonstrates common and widespread alterations in brain structure and 
chemistry in new-onset type 1 diabetes with ketoacidosis in a paediatric and 
adolescent cohort from a socio-economically and ethnically diverse population. There 
are several implications that arise from these findings. First, the imperative to avoid 
ketoacidosis in children through improved public and professional awareness. 
Reductions in the rates of ketoacidosis at diagnosis are possible, as has been 
demonstrated with public health campaigns in Italy and Australia (35, 36). Secondly, 
any neuroprotective strategy developed in the future must be prioritized at initial 
diagnosis. Finally, we should focus greater attention on neuropsychological 
evaluation of children with diabetes – both by performing a brief mental state 
examination in all newly diagnosed patients and with cognitive follow-up. It would 
appear sensible for clinicians to defer educational activities in patients with a 
suboptimal mental state for at least 1-2 weeks. Brain injury should no longer be 
considered a rare complication of DKA. This study has shown that it is both frequent 
and persistent. 
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Table 1: Patient characteristics  
 Non-DKA Group  
mean (range)  
n = 59  
DKA Group  
mean (range)  
n = 36  
p value  
Age (yrs) 11.52 (6.17-16.16)  11.52 (6.05-17.87)  0.99  
Percentage male  54.2  47.2  0.5 
Duration of 
polyuria/polydypsia (days)  
23.41 (2-168)  19.46 (1-56)  0.4  
SES (percentile) 61.51 (5-99) 60.58 (4-100) 0.99 
Percentage requiring school 
assistance  
15.8 16.7 >0.99 
At presentation:    
Lowest pH  7.37 (7.30-7.44)  7.12 (6.72-7.29)  <0.001  
Highest blood glucose 
(mmol/l)  
25.77 (13.00-45.10)  31.00 (16.00-81.00)  0.03  
Highest corrected serum 
sodium (mmol/l)  
139.69 (134-146)  147.99 (124-198)  <0.001  
Lowest corrected serum 
sodium (mmol/l) 
136.00 (133-141) 142.56 (128-169) 0.075 
Highest urea (mmol/l)  5.15 (2-8)  6.21 (3-13)  0.006  
Serum osmolality (mmol/l)  298.39 (285-318)  312.80 (264-394)  <0.001  
Percent dehydration*  
 
N/A  7.84 (0-14)  N/A 
At 6 month follow-up:    
Percentage  of patients with 1 
or more episodes of severe 
hypoglycaemia  
 
 (1.7%)  (2.8%) 0.3 
Percentage of patients with 1 
or more episodes of 
subsequent DKA. 
 
0% 0% - 
Percentage on: 
BD regimen 
MDI regimen 
 
 
78% (n=46) 
22% (n=13) 
 
74% (n=26) 
26% (n=9) 
 
 
0.7               
TDD (units/kg/day) 
 
0.7 (0-1.4) 0.8 (0.3-1.7) 0.016 
HbA1c -  at 6 months 
 
7.52 (5-12) 7.40 (5-9) 0.617 
IDAA1C 
 
10.2 (5.6-15.7) 10.6 (6.9-14.8) 0.205 
 
*Calculated as weight at discharge minus weight at presentation/weight at 
discharge. 
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Figure 1: Total brain volumes 
(a)                                                             (b)                                                                    (c)                                    
 
             
     
  (d)                                                                    (e) 
 
          
  
 
Figure legend: Data are presented as estimated means and 95% confidence intervals at each time point:  (a) total supratentorial brain volumes; (b) total 
supratentorial white matter volume; (c) total supratentorial grey matter volume * p=0.14; (d) total cortical white matter volume/total brain volume * p=0.008; (e) 
total cortical grey matter volume/total brain volume * p=0.008. The non-DKA group is depicted in blue and the DKA group is depicted in red. 
*
*
*
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Figure 2: Frontal lobe volumes, diffusivity and spectroscopy 
 
  Volumes                        Diffusivity           Spectroscopy -NAA   
                     
White Matter 
(a)                                                                          (b)                                                                              (c) 
                             
                            
Grey Matter 
(d)                                                                                  (e)                                                                              (f) 
                             
 
 
Figure legend: Data are presented as estimated means and 95% confidence intervals at each time point: (a) frontal lobe white matter relative volume 
*p=0.002; (b) frontal lobe white matter diffusivity *p<0.001; (c) frontal lobe white matter NAA *p=0.005; (d) frontal lobe grey matter relative volume; (e) frontal 
lobe grey matter diffusivity  *p=0.013; (f) frontal lobe grey matter NAA *p=0.005. The non-DKA group is depicted in blue and the DKA group is depicted in red. 
                                        
* *
* *
*
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 Figure 3: Mental state and cognition 
 
 
(a)                                                                         (b)                                                                             (c) 
                                  
  
(d)                                                                                  (e)                                                                            (f) 
                                
 
Figure legend: Data are presented as estimated means and 95% confidence intervals at each time point: (a) mental state (SYSTEMS) score *p=0.002; (b) 
long term memory score *p=0.002; (c) focused attention (Sky Search) score; (d) dual-modality divided attention (Sky Search DT) score; (e) single-modality 
divided attention (Score DT) score; (f) sustained attention/impulsivity (Walk/Don’t Walk) score. The non-DKA group is depicted in blue and the DKA group is 
depicted in red. 
*
*
